Insider · CIK 0001689575
Katherine Stueland
ceoofficerdirector
Files at WGS (GeneDx Holdings Corp.). First filing Oct 31, 2024, latest Sep 18, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 25
$0 bought, $30M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
WGSOct 9, 2026 · close 67.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | GeneDx Holdings Corp. | $1.0M 10,501 shares | -8% | - | |
| 32Weak | GeneDx Holdings Corp. | $311k 3,692 shares | -3% | - | |
| 53Moderate | GeneDx Holdings Corp. | $1.6M 10,857 shares | -43% | +151% from low-15% from high | |
| 47Moderate | GeneDx Holdings Corp. | $580k 3,639 shares | -36% | +185% from low-4% from high | |
| 42Moderate | GeneDx Holdings Corp. | $295k 2,158 shares | -39% | +134% from low-4% from high | |
| 58Moderate | GeneDx Holdings Corp. | $1.4M 12,858 shares | -88% | +154% from low-19% from high | |
| 53Moderate | GeneDx Holdings Corp. | $1.3M 10,501 shares | -42% | +229% from low-8% from high | |
| 52Moderate | GeneDx Holdings Corp. | $468k 3,657 shares | -37% | +257% from low-5% from high | |
| 41Moderate | GeneDx Holdings Corp. | $227k 2,154 shares | -39% | +160% from low-22% from high | |
| 47Moderate | GeneDx Holdings Corp. | $299k 3,220 shares | -65% | +161% from low-21% from high | |
| 56Moderate | GeneDx Holdings Corp. | $878k 9,657 shares | -66% | +156% from low-23% from high | |
| 49Moderate | GeneDx Holdings Corp. | $680k 10,501 shares | -42% | +90% from low-43% from high | |
| 41Moderate | GeneDx Holdings Corp. | $264k 3,639 shares | -36% | +105% from low-38% from high | |
| 41Moderate | GeneDx Holdings Corp. | $244k 2,154 shares | -39% | +232% from low0% from high | |
| 58Moderate | GeneDx Holdings Corp. | $4.2M 46,594 shares | -96% | +176% from low-14% from high | |
| 53Moderate | GeneDx Holdings Corp. | $4.5M 46,551 shares | -49% | +174% from low-14% from high | |
| 63Notable | GeneDx Holdings Corp. | $1.1M 11,637 shares | -150% | - | |
| 41Moderate | GeneDx Holdings Corp. | $259k 2,731 shares | -26% | - | |
| 39Weak | GeneDx Holdings Corp. | $130k 1,657 shares | -30% | - | |
| 58Moderate | GeneDx Holdings Corp. | $4.9M 51,420 shares | -97% | - | |
| 48Moderate | GeneDx Holdings Corp. | $1.4M 18,006 shares | -25% | - | |
| 45Moderate | GeneDx Holdings Corp. | $806k 10,501 shares | -13% | - | |
| 32Weak | GeneDx Holdings Corp. | $280k 3,661 shares | -6% | - | |
| 55Moderate | GeneDx Holdings Corp. | $3.2M 45,415 shares | -43% | - | |
| 36Weak | GeneDx Holdings Corp. | $143k 2,154 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 125,977 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,648 | $94.26 | $155k | 124,329 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -148 | $95.41 | $14k | 124,181 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,525 | $96.90 | $148k | 122,656 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -4,141 | $98.27 | $407k | 118,515 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,039 | $99.00 | $301k | 115,476 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 37,500 | 24 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,547 | $0.00 | $0 | 110,919 | 31 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,692 | $84.22 | $311k | 107,227 | 31 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,547 | $0.00 | $0 | 6,547 | 31 d ago |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 25,094 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -369 | $138.93 | $51k | 24,725 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,031 | $140.08 | $144k | 23,694 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,679 | $141.20 | $378k | 21,015 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -604 | $142.12 | $86k | 20,411 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -940 | $144.27 | $136k | 19,471 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,628 | $145.36 | $237k | 17,843 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,970 | $146.93 | $289k | 15,873 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -932 | $148.55 | $138k | 14,941 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -274 | $149.20 | $41k | 14,667 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -74 | $150.75 | $11k | 14,593 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -356 | $140.95 | $50k | 14,237 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 93,750 | Dec 18, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,547 | $0.00 | $0 | 9,983 | Dec 11, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,639 | $159.28 | $580k | 6,344 | Dec 11, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,547 | $0.00 | $0 | 26,186 | Dec 11, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,874 | $0.00 | $0 | 5,594 | Oct 31, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,154 | $136.54 | $294k | 3,440 | Oct 31, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -4 | $136.75 | $547 | 3,436 | Oct 31, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,874 | $0.00 | $0 | 7,748 | Oct 31, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -606 | $105.10 | $64k | 13,972 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,092 | $106.69 | $117k | 12,880 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -4,462 | $107.61 | $480k | 8,418 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,163 | $108.55 | $560k | 3,255 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -554 | $109.13 | $60k | 2,701 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -200 | $110.23 | $22k | 2,501 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -645 | $111.84 | $72k | 1,856 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -136 | $113.68 | $15k | 1,720 | Oct 1, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 25,079 | Sep 18, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -10,501 | $121.47 | $1.3M | 14,578 | Sep 18, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 112,500 | Sep 18, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,546 | $0.00 | $0 | 9,986 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,639 | $128.05 | $466k | 6,347 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -18 | $129.08 | $2,323 | 6,329 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,546 | $0.00 | $0 | 32,733 | Sep 11, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,874 | $0.00 | $0 | 5,594 | Jul 31, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,154 | $105.31 | $227k | 3,440 | Jul 31, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,874 | $0.00 | $0 | 11,622 | Jul 31, 2025 |
| Jul 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,220 | $93.00 | $299k | 1,720 | Jul 11, 2025 |
| Jul 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -6,928 | $90.68 | $628k | 7,669 | Jul 3, 2025 |
| Jul 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,594 | $91.55 | $237k | 5,075 | Jul 3, 2025 |
| Jul 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -135 | $92.46 | $12k | 4,940 | Jul 3, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 25,098 | Jun 18, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -10,501 | $64.77 | $680k | 14,597 | Jun 18, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 131,250 | Jun 18, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,547 | $0.00 | $0 | 9,987 | Jun 11, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,639 | $72.55 | $264k | 6,348 | Jun 11, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,547 | $0.00 | $0 | 39,279 | Jun 11, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,874 | $0.00 | $0 | 5,594 | May 1, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,154 | $113.09 | $244k | 3,440 | May 1, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,874 | $0.00 | $0 | 15,496 | May 1, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,024 | $81.16 | $164k | 46,290 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,134 | $82.17 | $258k | 43,156 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,297 | $83.25 | $274k | 39,859 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,745 | $84.28 | $231k | 37,114 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,175 | $85.44 | $271k | 33,939 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,855 | $86.34 | $506k | 28,084 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -373 | $87.30 | $33k | 27,711 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -300 | $88.70 | $27k | 27,411 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,600 | $90.13 | $144k | 25,811 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,900 | $91.27 | $173k | 23,911 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,000 | $92.28 | $92k | 22,911 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -9,628 | $93.33 | $899k | 13,283 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -4,511 | $94.55 | $427k | 8,772 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,173 | $95.51 | $303k | 5,599 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,174 | $96.29 | $306k | 2,425 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -705 | $97.24 | $69k | 1,720 | Apr 10, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +80,000 | $0.00 | $0 | 94,865 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -44,801 | $95.66 | $4.3M | 50,064 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,750 | $94.59 | $166k | 48,314 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -80,000 | $0.00 | $0 | 240,000 | Mar 28, 2025 |
| Mar 13, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,078 | $89.44 | $96k | 6,674 | Mar 17, 2025 |
| Mar 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 25,424 | Mar 17, 2025 |
| Mar 17, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -10,559 | $96.71 | $1.0M | 14,865 | Mar 17, 2025 |
| Mar 26, 2024 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +320,000 | $0.00 | $0 | 320,000 | Mar 17, 2025 |
| Mar 15, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +47,684 | $0.00 | $0 | 47,684 | Mar 17, 2025 |
| Mar 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 150,000 | Mar 17, 2025 |
| Mar 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,546 | $0.00 | $0 | 10,483 | Mar 11, 2025 |
| Mar 10, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,731 | $94.73 | $259k | 7,752 | Mar 11, 2025 |
| Mar 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,546 | $0.00 | $0 | 45,826 | Mar 11, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,874 | $0.00 | $0 | 5,594 | Jan 31, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,657 | $78.48 | $130k | 3,937 | Jan 31, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,874 | $0.00 | $0 | 19,370 | Jan 31, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -23,800 | $93.34 | $2.2M | 29,340 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -8,439 | $94.33 | $796k | 20,901 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -9,176 | $95.50 | $876k | 11,725 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -10,005 | $96.39 | $964k | 1,720 | Jan 10, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,654 | $75.47 | $200k | 68,492 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,051 | $76.54 | $157k | 66,441 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,417 | $77.88 | $266k | 63,024 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -4,078 | $78.58 | $320k | 58,946 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -4,242 | $79.68 | $338k | 54,704 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,564 | $80.47 | $126k | 53,140 | Jan 6, 2025 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +18,750 | $0.00 | $0 | 81,647 | Dec 18, 2024 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -10,501 | $76.75 | $806k | 71,146 | Dec 18, 2024 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -18,750 | $0.00 | $0 | 168,750 | Dec 18, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +6,547 | $0.00 | $0 | 66,558 | Dec 11, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,661 | $76.37 | $280k | 62,897 | Dec 11, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -6,547 | $0.00 | $0 | 52,372 | Dec 11, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,497 | $68.65 | $377k | 99,929 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -4,800 | $69.67 | $334k | 95,129 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -7,240 | $70.72 | $512k | 87,889 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,958 | $71.49 | $140k | 85,931 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,043 | $72.95 | $149k | 83,888 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,510 | $73.71 | $111k | 82,378 | Nov 19, 2024 |
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -60 | $74.34 | $4,460 | 82,318 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -800 | $66.60 | $53k | 81,518 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -459 | $67.94 | $31k | 81,059 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,151 | $68.98 | $217k | 77,908 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -6,186 | $70.15 | $434k | 71,722 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -8,580 | $70.91 | $608k | 63,142 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,131 | $71.83 | $225k | 60,011 | Nov 19, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,874 | $0.00 | $0 | 107,580 | Oct 31, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,154 | $66.60 | $143k | 105,426 | Oct 31, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,874 | $0.00 | $0 | 23,244 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.